Please provide your email address to receive an email when new articles are posted on . Researchers observed high lysolipid levels in those with acute respiratory distress syndrome (ARDS), which may ...

China: Researchers have found in a new study that pulmonary surfactant (PS) therapy significantly improves arterial blood gas parameters and clinical symptoms in infants with neonatal respiratory ...

Acute respiratory distress syndrome (ARDS) is an emergency situation in both children and adults, as it compromises the vital oxygen supply to the body. A new study published in JAMA Network Open ...

Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...

Pulmonary surfactants are a complex assembly of lipids and proteins that play a critical role in maintaining the stability of the alveolar air–liquid interface during breathing. Their primary function ...

Inhaled sevoflurane significantly reduced ventilator-free days and 90-day survival versus IV propofol in moderate to severe ARDS. Inhaled volatile sedatives grew in popularity for prolonged use in ...

Background: Extracorporeal membrane oxygenation (ECMO) has emerged as an advanced therapeutic option for managing acute respiratory distress syndrome (ARDS), especially severe cases of ARDS. However, ...

Researchers may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome (ARDS), particularly in the aftermath of respiratory ...

Researchers at Endeavor Health and Northwestern University have created an artificial intelligence-based tool to help doctors recognize an underdiagnosed, often fatal respiratory syndrome found in ...

Bayer has dropped an acute respiratory distress syndrome drug in phase 2 development for “scientific reasons,” the German pharma giant revealed in its latest earnings results. The company “decided not ...